Find Teriparatide manufacturers, exporters & distributors on PharmaCompass

bachem teriparatide

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 11 USDMF, 9 NDC API, 16 Listed Suppliers, $ API Reference Price

24 API Suppliers
11 USDMF
9 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

35 Drugs in Development

35 Drugs in Development

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers, 6 FDA Orange Book, 24 Europe, 2 Canada, 8 Australia, 1 South Africa, 3 Listed Dossiers

44 FDF Dossiers
6 FDA Orange Book
24 Europe
2 Canada
8 Australia
1 South Africa
3 Listed Dossiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

media
3 DATA COMPILATION #PharmaFlow
22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 23 Finished Drug Prices, 10 Annual Reports

globalSalesInformation
1 US Medicaid Prescriptions
23 Finished Drug Prices
10 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

marketPlace
4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents

patents
1 US Patents

REF. STANDARDS & IMPURITIES

1 Others

otherSolutions
1 Others

Bachem Teriparatide

Synopsis

ACTIVE PHARMA INGREDIENTS

24

API Suppliers

11

USDMF

0

CEP/COS

CEP/COS Certifications

0

JDMF

0

EU WC

0

KDMF

9

NDC API

0

VMF

16

Listed Suppliers

API REF. PRICE (USD/KG)

$

$ 1,626,720

MARKET PLACE

4

API

2

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

44

FDF Dossiers

6

FDA Orange Book

FDA (Orange Book)

24

Europe

2

Canada

8

Australia

1

South Africa

3

Listed Dossiers

35DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

1

Others

PATENTS & EXCLUSIVITIES

1

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

3

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

22

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

62,447,673

Annual Reports (USD Million)

10,552

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Click the button for full data set

Also known as: Parathar, Parathyroid hormone (1-34) (human), 52232-67-4, Teriparatida, Teriparatidum, Teriparatidum [latin]

Molecular Formula

C₁₈₁H₂₉₁N₅₅O₅₁S₂

Molecular Weight

4118 g/mol

InChI Key

OGBMKVWORPGQRR-UMXFMPSGSA-N

Teriparatide

A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

1 2D Structure

Teriparatide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid

2.1.2 InChI

InChI=1S/C181H291N55O51S2/c1-21-96(18)146(236-160(267)114(48-53-141(250)251)212-174(281)132(84-239)232-177(284)143(93(12)13)233-147(254)103(185)82-237)178(285)216-111(45-50-134(187)241)155(262)219-119(65-90(6)7)163(270)213-116(55-62-289-20)158(265)224-124(71-100-79-196-86-203-100)167(274)226-126(73-135(188)242)169(276)217-117(63-88(2)3)148(255)201-81-138(245)205-105(39-27-30-56-182)149(256)223-123(70-99-78-195-85-202-99)166(273)221-121(67-92(10)11)164(271)225-128(75-137(190)244)171(278)231-131(83-238)173(280)214-115(54-61-288-19)157(264)210-112(46-51-139(246)247)153(260)208-109(43-34-60-199-181(193)194)159(266)234-144(94(14)15)175(282)215-113(47-52-140(248)249)156(263)222-122(69-98-77-200-104-38-26-25-37-102(98)104)165(272)220-120(66-91(8)9)161(268)209-108(42-33-59-198-180(191)192)151(258)206-106(40-28-31-57-183)150(257)207-107(41-29-32-58-184)152(259)218-118(64-89(4)5)162(269)211-110(44-49-133(186)240)154(261)228-129(76-142(252)253)172(279)235-145(95(16)17)176(283)229-125(72-101-80-197-87-204-101)168(275)227-127(74-136(189)243)170(277)230-130(179(286)287)68-97-35-23-22-24-36-97/h22-26,35-38,77-80,85-96,103,105-132,143-146,200,237-239H,21,27-34,39-76,81-84,182-185H2,1-20H3,(H2,186,240)(H2,187,241)(H2,188,242)(H2,189,243)(H2,190,244)(H,195,202)(H,196,203)(H,197,204)(H,201,255)(H,205,245)(H,206,258)(H,207,257)(H,208,260)(H,209,268)(H,210,264)(H,211,269)(H,212,281)(H,213,270)(H,214,280)(H,215,282)(H,216,285)(H,217,276)(H,218,259)(H,219,262)(H,220,272)(H,221,273)(H,222,263)(H,223,256)(H,224,265)(H,225,271)(H,226,274)(H,227,275)(H,228,261)(H,229,283)(H,230,277)(H,231,278)(H,232,284)(H,233,254)(H,234,266)(H,235,279)(H,236,267)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,286,287)(H4,191,192,198)(H4,193,194,199)/t96-,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,143-,144-,145-,146-/m0/s1

2.1.3 InChI Key

OGBMKVWORPGQRR-UMXFMPSGSA-N

2.1.4 Canonical SMILES

CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N

2.1.5 Isomeric SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N

2.2 Synonyms

2.2.1 MeSH Synonyms

1. Hpth (1-34)

2. Human Parathyroid Hormone (1-34)

3. Parathar

4. Teriparatide

5. Teriparatide Acetate

2.2.2 Depositor-Supplied Synonyms

1. Parathar

2. Parathyroid Hormone (1-34) (human)

3. 52232-67-4

4. Teriparatida

5. Teriparatidum

6. Teriparatidum [latin]

7. Teriparatida [spanish]

8. Human Parathyroid Hormone (1-34)

9. Human Pth (1-34)

10. Unii-10t9csu89i

11. (1-34)-human Parathormone

12. 1-34-parathormone (human)

13. Parathyroid Hormone (1-34)

14. Mn 10t

15. Hsdb 7367

16. Hpth (1-34)

17. Mn 10-t

18. Teriparatide [usan:inn:ban:jan]

19. Parathyroid Hormone Peptide (1-34)

20. Hpth- (1-34)

21. Zt 034

22. 10t9csu89i

23. Chebi:135983

24. Pth 1-34

25. Akos015994659

26. Hs-2025

2.3 Create Date

2007-07-04

3 Chemical and Physical Properties

Molecular Formula	C₁₈₁H₂₉₁N₅₅O₅₁S₂
Molecular Weight	4118 g/mol
XLogP3	-18.7
Hydrogen Bond Donor Count	60
Hydrogen Bond Acceptor Count	62
Rotatable Bond Count	146
Exact Mass	4116.1342973 g/mol
Monoisotopic Mass	4115.1309424 g/mol
Topological Polar Surface Area	1800 Å²
Heavy Atom Count	289
Formal Charge	0
Complexity	9740
Isotope Atom Count	0
Defined Atom Stereocenter Count	34
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Therapeutic Uses

Bone Density Conservation Agents

National Library of Medicine, SIS; ChemIDplus Record for Teriparatide (52232-67-4), MESH Heading. Available from, as of March 15, 2006: https://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp

Forteo is indicated for the treatment of postmenopausal women with osteoporosis who are at high risk for fracture. These include women with a history of osteoporotic fracture, or who have multiple risk factors for fracture, or who have failed or are intolerant of previous osteoporosis therapy, based upon physician assessment. In postmenopausal women with osteoporosis, forteo increases BMD and reduces the risk of vertebral and nonvertebral fractures.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1741

Forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture. These include men with a history of osteoporotic fracture, or who have multiple risk factors for fracture, or who have failed or are intolerant to previous osteoporosis therapy, based upon physician assessment. In men with primary or hypogonadal osteoporosis, forteo increases BMD. The effects of forteo on risk for fracture in men have not been studied.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1741

4.2 Drug Warning

In male and female rats, teriparatide caused an increase in the incidence of osteosarcoma (a malignant bone tumor) that was dependent on dose and treatment duration. The effect was observed at systemic exposures to teriparatide ranging from 3 to 60 times the exposure in humans given a 20-ug dose. Because of the uncertain relevance of the rat osteosarcoma finding to humans, teriparatide should be prescribed only to patients for whom the potential benefits are considered to outweigh the potential risk. Teriparatide should not be prescribed for patients who are at increased baseline risk for osteosarcoma (including those with Paget's disease of bone or unexplained elevations of alkaline phosphatase, open epiphyses, or prior external beam or implant radiation therapy involving the skeleton).

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

Adverse effects reported to have been increased by teriparatide treatment in clinical trials included leg cramps and dizziness. Adverse effects reported in at least 2% of patients receiving teriparatide and more frequently than with placebo but without attribution of causality include pain, arthralgia, rhinitis, asthenia, nausea, dizziness, headache, hypertension, increased cough, pharyngitis, constipation, dyspepsia, diarrhea, rash, insomnia, depression, pneumonia, vertigo, dyspnea, neck pain, vomiting, syncope, leg cramps, angina pectoris, GI disorder, sweating, or tooth disorder.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2005. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2005 (Plus Supplements)., p. 3088

In short-term clinical pharmacology studies with teriparatide, transient episodes of symptomatic orthostatic hypotension were observed infrequently. Typically, an event began within 4 hours of dosing and spontaneously resolved within a few minutes to a few hours. When transient orthostatic hypotension occurred, it happened within the first several doses, it was relieved by placing the person in a reclining position, and it did not preclude continued treatment.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1741

The safety and efficacy of forteo have not been evaluated beyond 2 years of treatment. Consequently, use of the drug for more than 2 years is not recommended. In clinical trials, the frequency of urolithiasis was similar in patients treated with forteo and placebo. However, forteo has not been studied in patients with active urolithiasis. If active urolithiasis or pre-existing hypercalciuria are suspected, measurement of urinary calcium excretion should be considered. Forteo should be used with caution in patients with active or recent urolithiasis because of the potential to exacerbate this condition.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1741

For more Drug Warnings (Complete) data for TERIPARATIDE (13 total), please visit the HSDB record page.

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Bone Density Conservation Agents

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)

Calcium-Regulating Hormones and Agents

Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)

5.2 Absorption, Distribution and Excretion

Systemic clearance of teriparatide (approximately 62 L/hr in women and 94 L/hr in men) exceeds the rate of normal liver plasma flow, consistent with both hepatic and extra-hepatic clearance. Volume of distribution, following intravenous injection, is approximately 0.12 L/kg. Intersubject variability in systemic clearance and volume of distribution is 25% to 50%.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

Teriparatide is extensively absorbed after subcutaneous injection; the absolute bioavailability is approximately 95% based on pooled data from 20-, 40-, and 80-ug doses. The rates of absorption and elimination are rapid. The peptide reaches peak serum concentrations about 30 minutes after subcutaneous injection of a 20-ug dose and declines to non-quantifiable concentrations within 3 hours.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

5.3 Biological Half-Life

The half-life of teriparatide in serum is 5 minutes when administered by intravenous injection and approximately 1 hour when administered by subcutaneous injection. The longer half-life following subcutaneous administration reflects the time required for absorption from the injection site.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

5.4 Mechanism of Action

The skeletal effects of teriparatide depend upon the pattern of systemic exposure. Once-daily administration of teriparatide stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity. In monkey studies, teriparatide improved trabecular microarchitecture and increased bone mass and strength by stimulating new bone formation in both cancellous and cortical bone. In humans, the anabolic effects of teriparatide are manifest as an increase in skeletal mass, an increase in markers of bone formation and resorption, and an increase in bone strength. By contrast, continuous excess of endogenous PTH, as occurs in hyperparathyroidism, may be detrimental to the skeleton because bone resorption may be stimulated more than bone formation.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

Endogenous 84-amino-acid parathyroid hormone (PTH) is the primary regulator of calcium and phosphate metabolism in bone and kidney. Physiological actions of PTH include regulation of bone metabolism, renal tubular reabsorption of calcium and phosphate, and intestinal calcium absorption. The biological actions of PTH and teriparatide are mediated through binding to specific high-affinity cell-surface receptors. Teriparatide and the 34 N-terminal amino acids of PTH bind to these receptors with the same affinity and have the same physiological actions on bone and kidney. Teriparatide is not expected to accumulate in bone or other tissues.

Physicians Desk Reference 60th ed, Thomson PDR, Montvale, NJ 2006., p. 1739

API SUPPLIERS

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Bachem Americas Inc

Switzerland

Swiss RNA Therapeutics

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

Contact Supplier

Switzerland

Digital Content

PARATHYROID HORMONE (1-34) HUMAN

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 8509

Submission : 1990-04-04

Status : Active

Type : II

Bachem company banner

Product Web Link

Digital Content

02

Alembic Pharmaceuticals Ltd

India

BIO Partnering at JPM

Not Confirmed

03

Amphastar Nanjing Pharmaceuticals In...

U.S.A

BIO Partnering at JPM

Not Confirmed

04

Auro Peptides Ltd

India

BIO Partnering at JPM

Not Confirmed

05

Chengdu Shengnuo Biopharm Co Ltd

China

BIO Partnering at JPM

Not Confirmed

06

Hybio Pharmaceutical Co Ltd

China

BIO Partnering at JPM

Not Confirmed

07

Hybio Pharmaceutical Co Ltd

China

BIO Partnering at JPM

Not Confirmed

08

Msn Life Sciences Private Ltd

India

BIO Partnering at JPM

Not Confirmed

09

Scinopharm Taiwan Ltd

Taiwan

BIO Partnering at JPM

Not Confirmed

10

Sun Pharmaceutical Industries Ltd

India

BIO Partnering at JPM

Not Confirmed

Only 10 entries up to this point, click to access all

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692642600,"product":"TERIPARATIDE USP","address":"MSN HOUSEPLOT NO.C-24INDUSTRIAL ESTATE SANATH NAGAR","city":"Hyderabad","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NA","customer":"TO THE ORDER OF","customerCountry":"KOREA, REPUBLIC OF","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"4002433.1","totalValueFC":"3971.7","currency":"USD","unitRateINR":328999992.59999996,"date":"22-Aug-2023","totalValueINR":"328999.9926","totalValueInUsd":"3971.7","indian_port":"HYDERABAD ICD","hs_no":"29371900","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SOUTH KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"MSN HOUSEPLOT NO.C-24INDUSTRIAL ESTATE SANATH NAGAR, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"TERIPARATIDE ACETATE","address":"2ND FLOOR, PLOT NO.2,","city":"HYDERABAD, AP.","supplier":"AURO PEPTIDES LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"ASAHI KASEI PHARMA","customerCountry":"JAPAN","quantity":"0.00","actualQuantity":"0.225","unit":"GMS","unitRateFc":"15022.2","totalValueFC":"3146.7","currency":"USD","unitRateINR":1169064.5333333334,"date":"31-Jul-2024","totalValueINR":"263039.52","totalValueInUsd":"3146.7","indian_port":"Hyderabad Air","hs_no":"29371900","bill_no":"2850079","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"2ND FLOOR, PLOT NO.2,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"TERIPARATIDE","year":"2021","qtr":"Q2","strtotime":1622226600,"product":"TERIPARATIDE M400062 - 3019-0218-01","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"RECIPHARM AB","supplierCountry":"FRANCE","foreign_port":"","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025718","unit":"KGS","unitRateFc":"3332999.9","totalValueFC":"106447.9","currency":"EUR","unitRateINR":"303182069.8","date":"29-May-2021","totalValueINR":"7797236.47","totalValueInUsd":"106447.9","indian_port":"HYDERABAD AIR","hs_no":"29371900","bill_no":"4131290","productDescription":"API","marketType":"REGULATED MARKET","country":"FRANCE","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"7-1-27, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623349800,"product":"PARATHYROID HORMONE (1-34) HUMAN ACETATE TERIPARATIDE - 30-19-0280-01","address":"NO.201, PHASE II GOLDEN PARKAPARTMENTS, KODICHIKANAHALLI,","city":"BANGALORE","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NEW YORK","customer":"STELIS BIOPHARMA","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"15","unit":"GMS","unitRateFc":"4500","totalValueFC":"68675.5","currency":"USD","unitRateINR":"336719","date":"11-Jun-2021","totalValueINR":"5050785","totalValueInUsd":"68675.5","indian_port":"BANGALORE AIR","hs_no":"29371900","bill_no":"4284178","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NEW YORK","supplierAddress":"","customerAddress":"NO.201, PHASE II GOLDEN PARKAPARTMENTS, KODICHIKANAHALLI,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635359400,"product":"TERIPARATIDE (PARATHYROID HORMONE (1-34) HUMAN, ACETATE)(30-21-0096-01)(2G)","address":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR","city":"KUKATPALLY HYDERABAD,TELANGANA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.002","unit":"KGS","unitRateFc":"3800000","totalValueFC":"8094.8","currency":"USD","unitRateINR":"303200000","date":"28-Oct-2021","totalValueINR":"606400","totalValueInUsd":"8094.8","indian_port":"HYDERABAD AIR","hs_no":"29371900","bill_no":"6042111","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637778600,"product":"(0.030GMS) TERIPARATIDE(PARATHYROID HORMONE(1-34))HUMAN,ACETATE IMPURITES PTH(1-31)( SAMPLE FOR R&D PURPOSE ONLY)","address":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR","city":"KUKATPALLY HYDERABAD,TELANGANA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00003","unit":"KGS","unitRateFc":"70000000","totalValueFC":"2117.7","currency":"USD","unitRateINR":"5257000000","date":"25-Nov-2021","totalValueINR":"157710","totalValueInUsd":"2117.7","indian_port":"HYDERABAD AIR","hs_no":"29371900","bill_no":"6401946","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640197800,"product":"TERIPARATIDE ACETATE (TEST LIC.NO. TL\/AZ\/20\/000934) FOR R &D PURPOSE NOT FOR SALE","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NEW YORK - JOHN F. K","customer":"ZYDUS LIFESCIENCES","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"30","unit":"GMS","unitRateFc":"3600","totalValueFC":"110879.7","currency":"USD","unitRateINR":"278774.2","date":"23-Dec-2021","totalValueINR":"8363226.64","totalValueInUsd":"110879.7","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"6811293","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NEW YORK - JOHN F. K","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"AC-PTH (1-34) TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"S-34-F[MET(0)18] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"S-34-F[MET(0)8] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"TERIPARATIDE (PARATHYROID HORMONE (1-34) HUMAN, ACETATE LOTNO.30-21-0096-01","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"3637500","totalValueFC":"2024.7","currency":"USD","unitRateINR":"308645300","date":"22-Mar-2022","totalValueINR":"154322.65","totalValueInUsd":"2024.7","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"[D-GLN6] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"[D-GLU4] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"[D-HIS14] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"[D-MET18] TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647887400,"product":"[DARG20] PTH (1-34) TERIPARATIDE (10 MG)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00001","unit":"KGS","unitRateFc":"37500000","totalValueFC":"417.5","currency":"USD","unitRateINR":"3181908000","date":"22-Mar-2022","totalValueINR":"31819.08","totalValueInUsd":"417.5","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"7968829","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659465000,"product":"TERIPARATIDE (PARATHYROID HORMONE (1-34)) HUMAN, ACETATE, LOT NO:30-20-0289-01 (6 GMS)","address":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"4150000","totalValueFC":"26531.2","currency":"USD","unitRateINR":"351835291.7","date":"03-Aug-2022","totalValueINR":"2111011.75","totalValueInUsd":"26531.2","indian_port":"AHMEDABAD AIR","hs_no":"29371900","bill_no":"9848216","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"901-911 9TH FLR ISCON ELEGANCE NR SHAPATH 5 S G HIGHWAY Contact No: 9"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664562600,"product":"TERIPARATIDE (QTY:11 X 1 MG, PRICE USD:17.55\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"AUSTRIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000011","unit":"KGS","unitRateFc":"17550000","totalValueFC":"193.1","currency":"USD","unitRateINR":"1444480909","date":"01-Oct-2022","totalValueINR":"15889.29","totalValueInUsd":"193.1","indian_port":"HYDERABAD AIR","hs_no":"29371900","bill_no":"2692739","productDescription":"API","marketType":"REGULATED MARKET","country":"AUSTRIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664562600,"product":"TERIPARATIDE (QTY:26 X 1 MG, PRICE USD:17.55\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"AUSTRIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000026","unit":"KGS","unitRateFc":"17550000","totalValueFC":"456.4","currency":"USD","unitRateINR":"1444481154","date":"01-Oct-2022","totalValueINR":"37556.51","totalValueInUsd":"456.4","indian_port":"HYDERABAD AIR","hs_no":"29371900","bill_no":"2692739","productDescription":"API","marketType":"REGULATED MARKET","country":"AUSTRIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666981800,"product":"PARATHYROID HORMONE (1-34), HUMAN,ACETATE (TERIPARATIDE)(0.2G)","address":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR","city":"KUKATPALLY HYDERABAD,TELANGANA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"3800000","totalValueFC":"1692.6","currency":"USD","unitRateINR":"696370000","date":"29-Oct-2022","totalValueINR":"139274","totalValueInUsd":"1692.6","indian_port":"HYDERABAD AIR","hs_no":"29379090","bill_no":"3088989","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676658600,"product":"TERIPARATIDE ACETATE (TL NO: TL\/AZ\/20\/000934) FOR R&D PURPOSE NOT FOR SALE","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"2","unit":"GMS","unitRateFc":"3600","totalValueFC":"7593.5","currency":"USD","unitRateINR":"313575.7","date":"18-Feb-2023","totalValueINR":"627151.45","totalValueInUsd":"7593.5","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"4706488","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676658600,"product":"TERIPARATIDE ACETATE (TL NO: TL\/AZ\/20\/000934)FOR R&D PURPOSENOT FOR SALE","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"2","unit":"GMS","unitRateFc":"3600","totalValueFC":"7593.5","currency":"USD","unitRateINR":"313575.7","date":"18-Feb-2023","totalValueINR":"627151.45","totalValueInUsd":"7593.5","indian_port":"BOMBAY AIR","hs_no":"29371900","bill_no":"4706488","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679337000,"product":"PARATHYROID HORMONE (1-34), HUMAN,ACETATE (TERIPARATIDE) (30G)","address":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR","city":"KUKATPALLY HYDERABAD,TELANGANA","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"3600000","totalValueFC":"109903.5","currency":"USD","unitRateINR":"301320000","date":"21-Mar-2023","totalValueINR":"9039600","totalValueInUsd":"109903.5","indian_port":"HYDERABAD AIR","hs_no":"29379090","bill_no":"5161922","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P. NO 53, ALEAP INDUSTRIAL ESTATE, ,GAJULARAMARAM BEHIND PRAGATHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681410600,"product":"TERIPARATIDE ACETATE (TEST LIC: TL\/AZ\/20\/000934) FOR R&D PURPOSE NOT FOR SALE","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"2","unit":"GMS","unitRateFc":"3600","totalValueFC":"7775.7","currency":"USD","unitRateINR":"318624.2","date":"14-Apr-2023","totalValueINR":"637248.49","totalValueInUsd":"7775.7","indian_port":"BOMBAY AIR","hs_no":"29379090","bill_no":"5513771","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697999400,"product":"PARATHYROID HORMONE (1-34),HUMAN, ACETATE (TERIPARATIDE) (29G)","address":"H NO.141, SILPA BRINDAVAN,","city":"KUKATPALLY, HYDERABAD, AP.","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"LOS ANGELES","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.029","unit":"KGS","unitRateFc":"3600000","totalValueFC":"106528.1","currency":"USD","unitRateINR":"305733103.5","date":"23-Oct-2023","totalValueINR":"8866260","totalValueInUsd":"106528.1","indian_port":"Hyderabad Air","hs_no":"29379090","bill_no":"8429825","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"LOS ANGELES","supplierAddress":"365 Maple Avenue Torrance, CA 90503USA United StatesSDNF United States","customerAddress":"H NO.141, SILPA BRINDAVAN,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721586600,"product":"PARATHYROID HORMONE (1-34), HUMAN, ACETATE (TERIPARATIDE) (0.5G)","address":"H NO.141, SILPA BRINDAVAN,","city":"KUKATPALLY, HYDERABAD, AP.","supplier":"POLYPEPTIDE GROUP","supplierCountry":"UNITED STATES","foreign_port":"LOS ANGELES","customer":"ORBICULAR PHARMACEUTICAL TECHNOLOGIES ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"3600000","totalValueFC":"2731","currency":"USD","unitRateINR":"456570000","date":"22-Jul-2024","totalValueINR":"228285","totalValueInUsd":"2731","indian_port":"Hyderabad Air","hs_no":"29379090","bill_no":"4646724","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"LOS ANGELES","supplierAddress":"365 Maple Avenue - Torrance - CA -90503 - United StatesSDNF United States","customerAddress":"H NO.141, SILPA BRINDAVAN,"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

01

Accord Healthcare AG

United Kingdom

BIO Partnering at JPM

Not Confirmed

02

ELI LILLY NEDERLAND BV

U.S.A

BIO Partnering at JPM

Not Confirmed

03

Eli Lilly Netherlands BV

U.S.A

BIO Partnering at JPM

Not Confirmed

04

Gedeon Richter Plc

Hungary

BIO Partnering at JPM

Not Confirmed

05

Gedeon Richter Plc

Hungary

BIO Partnering at JPM

Not Confirmed

06

Gedeon Richter (Schweiz) AG

Hungary

BIO Partnering at JPM

Not Confirmed

07

ITALFARMACO SPA

Italy

BIO Partnering at JPM

Not Confirmed

08

Mepha Pharma AG

Switzerland

BIO Partnering at JPM

Not Confirmed

09

Orifarm AS

Denmark

BIO Partnering at JPM

Not Confirmed

10

Stada Arzneimittel AG

Germany

BIO Partnering at JPM

Not Confirmed

Only 10 entries up to this point, click to access all

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

Tender// Teriparatide API needed by National Services Scotland [ENA09016]

The Common Services Agency (more commonly known as NHS National Services Scotland) is looking for supply of Teriparatide API to NHS Scotland. The Authority intends to award this framework as a unranked multi-supplier framework per line to a maximum of four (4) Framework Participants. The deadline for the submission of the bid is 12-Nov--2020.

Reply

09 Nov 2020

BP Grade Teriparatide (750 mcg/ 3 ml) Pre-filled Syringe needed in India [ENA07383]

Creation Parenterals, a pharmaceutical company that deals in the manufacturing of Injectables (ampoules and vials), eye and ear drops is looking for suppliers of BP Grade Teriparatide (750 mcg/ 3 ml) Pre-filled Syringe. The required quantity is 40,000 units. The final market is the UK. Interested suppliers can contact them via their email: parvezbpharma@gmail.com.

Reply

23 May 2020

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Others

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Teriparatide Manufacturers

A Teriparatide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Teriparatide, including repackagers and relabelers. The FDA regulates Teriparatide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Teriparatide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Teriparatide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Teriparatide Suppliers

A Teriparatide supplier is an individual or a company that provides Teriparatide active pharmaceutical ingredient (API) or Teriparatide finished formulations upon request. The Teriparatide suppliers may include Teriparatide API manufacturers, exporters, distributors and traders.

click here to find a list of Teriparatide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Teriparatide USDMF

A Teriparatide DMF (Drug Master File) is a document detailing the whole manufacturing process of Teriparatide active pharmaceutical ingredient (API) in detail. Different forms of Teriparatide DMFs exist exist since differing nations have different regulations, such as Teriparatide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Teriparatide DMF submitted to regulatory agencies in the US is known as a USDMF. Teriparatide USDMF includes data on Teriparatide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Teriparatide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Teriparatide suppliers with USDMF on PharmaCompass.

Teriparatide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Teriparatide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Teriparatide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Teriparatide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Teriparatide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Teriparatide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Teriparatide suppliers with NDC on PharmaCompass.

Teriparatide GMP

Teriparatide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Teriparatide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Teriparatide GMP manufacturer or Teriparatide GMP API supplier for your needs.

Teriparatide CoA

A Teriparatide CoA (Certificate of Analysis) is a formal document that attests to Teriparatide's compliance with Teriparatide specifications and serves as a tool for batch-level quality control.

Teriparatide CoA mostly includes findings from lab analyses of a specific batch. For each Teriparatide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Teriparatide may be tested according to a variety of international standards, such as European Pharmacopoeia (Teriparatide EP), Teriparatide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Teriparatide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Market Place

Home

Menu

Post Enquiry

Market Place

Search